SUBMISSION CHECKLIST

To be completed and uploaded with the manuscript at submission.

Incomplete submissions will not be put into the peer-review process until requirements are met. Incomplete
submissions will be removed from the system after 90 days.

A more complete description of each item that must be checked, including ethical considerations, is provided
under the appropriate heading in the Information for Authors document available at www.archives-pmr.org.
All elements of the manuscript are printed in English and double-spaced with 1-inch margins at top, bottom, and
sides. Right margins are unjustified.
Separate documents are submitted in the following order: (1) cover letter; (2) title page, including
acknowledgments and explanation of any conflicts of interest; (3) main text file (manuscript without author
identifiers) including a structured or standard abstract, keywords, list of abbreviations, body of the text,
references, suppliers’ list, figure legends; (4) figures; (5) tables; (6) appropriate completed reporting guideline (e.g.
CONSORT, PRISMA, etc.) (7) appendices; (8) supplementary files; (9) author checklist; (10) disclosure forms (ICMJE
Form for Disclosure of Potential Conflicts of Interest.
Cover Letter
The cover letter should include essential information, including who the corresponding author will be and a
statement signed by the corresponding author that written permission has been obtained from all persons named
in the Acknowledgments and patient consent forms have been collected, if needed.
Title Page
These elements are in the following sequence and are typed double-spaced.
☐Running head of no more than 40 character spaces.
☐Title.
☐Author(s) full name(s) written as First Name then Last Name, and highest academic degree(s).
☐The name(s) of the institution(s), section(s), division(s), and department(s) where the study was performed and
the institutional affiliation(s) of the author(s) at the time of the study. An asterisk after an author’s name and a
footnote may indicate a change in affiliation.
☐Acknowledgment of any presentation of this material, to whom, when, and where.
☐Acknowledgment of financial support, including grant numbers.
☐Explanation of any conflicts of interest.
☐Name, address, business telephone number, and e-mail address of corresponding author and the author from
whom reprints can be obtained.
☐If reprints are not available, this is stated on the title page.
☐Clinical trial registration number, if applicable.
Manuscript Body
☐Archives uses a double-blind peer-review process. The blinded submission should be submitted in a word
document and should begin with a title followed by the abstract and then the text.
☐This document is consecutively line numbered.
☐If this is a randomized controlled trial, provide the CONSORT flow diagram
(http://www.consort-statement.org/Downloads/flowchart.doc).
☐Statement is included in the body of the manuscript that human experimentation has been approved by the
local institutional review board or conforms to Helsinki Declaration, as stated in the section Manuscript
Preparation, Methods.
☐Guidelines for the care/use of nonhuman animals or other species, approved by the institution, have been
followed as indicated in the Methods. The species is named in the title, abstract, and Methods section.
☐It is recommended that a professional editor or a colleague fluent in English edit the manuscript before
submission for authors whose first language is not English.
☐The body of the manuscript includes the Introduction (no heading needed), Methods, Results, Discussion, Study
Limitations (subheading), and Conclusions headings. Longer articles may need other subsection headings to clarify
their content, especially the Results and Discussion sections. Other types of articles such as Commentaries and
Special Communications do not require this format.
☐Footnotes other than for references are not allowed in the manuscript body.
Abstract
☐For Original Research Articles, Brief Reports, and Review Articles, a structured abstract of 275 words or fewer
with Key Words is included before the body of the manuscript and is headed by the title. Note that original
research and reviews have different formats for their abstracts.
☐ For other manuscripts (e.g., Commentaries, Editorials and Special Communications), include a conventional,
unstructured abstract of no more than 250 words with Key Words before the body of the manuscript and headed
by the title.
Abbreviations
☐Authors should include a list of abbreviations in their manuscript file following the abstract (just above
introduction). Archives uses only standard abbreviations with Davis’s and Dorland’s as our guides. Abbreviations
that are used ONLY in tables, appendices, or figures are not included in the list and should be defined in the
relevant table, appendix, or figure note; however, abbreviations that are in the list need not be re-defined in a
table footnote or legend. All abbreviations must be defined on first mention in the body of the manuscript. The
abbreviations SD (standard deviation) and SE (standard error) require no definition in Archives.
References
☐All references have been checked for accuracy and completeness.
☐All references are numbered consecutively in the order they are cited in the text; all listed references have been
cited in the text.
☐For any reference cited as "in press," a copy of the article is included.
☐Personal communications and unpublished observations are not used as numbered references but are
mentioned in the text with the written approval of the person being quoted. Author must include a copy of the
approval.
☐Suppliers are not listed in the reference list or included in the reference numbering (see below).
Suppliers
☐Provide a list (after the Reference section) including all manufacturers and other nondrug products used directly
in the study. They should be in an alphabetized, superscripted list (i.e., a, b, c…).
☐Provide names for each Supplier.
☐Equipment and/or materials are identified in text, tables, and legends by superscript lower case letters,
corresponding to the list of suppliers.
☐Suppliers are listed consecutively in the order they are cited in the text. Figure Legends
☐A list of figure legends should be provided after the reference list and suppliers’ list, listing each figure in order
by number.
☐Legends/captions should not be embedded in the figure files themselves.
Figures
☐Each is numbered with an Arabic numeral and cited in numeric sequence in the text.
☐Each figure is provided in a separate document
☐Photographs of recognizable persons require a signed release from the patient or legal guardian authorizing
publication. Masking eyes to hide identity is not sufficient. (Author should be able to provide signed release forms
when requested.)
☐If a CONSORT diagram is included, it should be assigned a figure number and be included with the list of figure
legends.
☐Figures should be submitted in PDF, JPG, EPS, or TIFF format.
Tables
☐Each table is provided in a separate document, headed by a title, and numbered in
Arabic numerals.
☐Tables are cited in numeric sequence in the text.
☐Tables should be submitted in Word or as a PDF. Please do not import tables into a
Word document.
☐Reporting Guidelines
To ensure a high and consistent quality of research reporting, original research articles must
contain sufficient information to allow readers to understand how a study was designed and
conducted. For review articles, systematic or narrative, readers should be informed of the
rationale and details behind the literature search strategy. To achieve this goal, Archives,
requires that authors upload a completed checklist for the appropriate reporting guideline
during original submission. The Archives specifically requests that the following Reporting Guidelines
are used when appropriate and strongly encourages authors to use any of the Guidelines listed in the
Equator Network (www.equator-network.org):
Randomized Controlled Trials – CONSORT - Consolidated Standards of Reporting Trials
Observational Studies – STROBE – Strengthening the Reporting of Observational studies in
Epidemiology
Systematic Review of Controlled Trials – PRISMA – Preferred Reporting Items for Systematic
Reviews and Meta-Analyses
 Study of Diagnostic accuracy/assessment scale – STARD – Standards for the Reporting of
Diagnostic Accuracy Studies
Case Reports – CARE – for case reports

Highlights and Graphical Abstracts (optional)

☐Highlights are a short collection of bullet points that convey the core findings and provide readers with a quick
textual overview of the article. Highlights should be submitted as a separate MS Word file in EES by selecting
"Highlights" from the drop-down list when uploading files. Include 3 to 5 highlights. There should be a maximum of
85 characters, including spaces, per highlight. Only the core results of the paper should be covered. See
http://www.elsevier.com/journal-authors/highlights
☐For Graphical Abstracts, authors must provide an image that clearly represents the work described in the paper.
A key figure from the original paper, summarizing the content can also be submitted as a graphical abstract.
Graphical Abstracts should be submitted as a separate file in EES by selecting “Graphical Abstracts" from the drop-
down list when uploading files. Preferred file types are TIFF, EPS, PDF or MS Office files. See
http://www.elsevier.com/journal- authors/graphical-abstract
Similar Publication
☐Upload with the manuscript files a reprint of each article and/or abstract the author and/or coauthors have
previously published or is “in press,” and each manuscript the author and/or coauthors have submitted for
possible publication or have in manuscript form dealing with the same patients, animals, laboratory experiment, or
data, in part or in full, as those reported in the submitted manuscript. Further explanation of the circumstances
should be included in the cover letter, including similarities and differences.

Disclosure Forms
The ICMJE form only needs to be submitted for the corresponding author at the time of the original
submission. But ICMJE forms will be needed from all authors should the manuscript move into the
revision phase.

DEVICE STATEMENT
Please check off ONE statement below that pertains to your submitted work.

o The manuscript submitted does not contain information about medical device(s).

o The device(s) is/are FDA approved for the indicated usage in the United States.

o The legal/regulatory status of the device(s) that is/are the subject of this manuscript is/are not
applicable in the country where the author(s) resides.

o The device(s) that is/are the subject of this manuscript has/have been cleared through the
Premarket Notification (510(k)) process/approved through a Premarket Approval application for
the indications studied.

o The device(s) that is/are the subject of this manuscript has/have been cleared through the
Premarket Notification (510(k)) process/approved through a Premarket Approval application for
[state the specific indication on a separate page and attach], but not for the indications that
were reported.

o The device(s) that is/are the subject of this manuscript is/are being evaluated as part of an
ongoing FDA-approved investigational protocol (DE) for [state the intended use on a separate
 page and attach].

o The device(s) that is/are the subject of this manuscript is/are exempt from FDA regulations
because [state reason on a separate page and attach].

o The device(s) that is/are the subject of this manuscript is/are not FDA-approved and is/are not
commercially available in the United States.

o The device(s) that is/are the subject of this manuscript is/are not intended for human use.

o The legal/regulatory status of the device(s) that is/are subject of this manuscript is/are not
known by the author(s).

Permissions
☐Signed, written permission from both the copyright holder and the original author for the use of tables, figures,
or quotations previously published and their complete references is on file with the author and can be submitted
to the editorial office upon request.
☐Signed, written permission for the use of quotations of personal communications and unpublished data has been
obtained from the person(s) being quoted and is included with the submission.
☐Informed consent and releases to publish photographs of recognizable persons should
be on file with the author and submitted to the editorial office upon request. Submit with the manuscript written
permission to use nonoriginal material (quotations exceeding 100 words, any table or illustration) from both
author and publisher of the original. No article will be accepted as a submission to Archives without all required
permissions. Credit the source in a text or table note or in a legend.
Resubmissions
☐When resubmitting a manuscript for further consideration, provide an itemized accounting of how the
manuscript was changed in response to the original set of evaluations. Also, a highlighted or marked-up (Track
Changes) copy should be submitted showing all of the changes made throughout the manuscript.
☐Both a clean and marked-up copy of the manuscript files that were revised are required at submission.
I have reviewed this Checklist and have complied with its requirements.
Type in name above Type in date above